Submitted by Anonymous (not verified) on 26 February 2026 - 14:04
Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation: 17/08/2022, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation: 17/08/2022, Revision: 8, Status: Authorised